Confluence Wealth Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Confluence Wealth Services's AZN Position: Q2 2026 in Review
Confluence Wealth Services opened a new position in AstraZeneca (AZN) in Q2 2026: 4,292 shares worth $814K. The stake represents 0.02% of the portfolio and ranks #263 among its holdings. This is a return to the name: Confluence Wealth Services previously reported a position in AZN as recently as Q4 2025.
Confluence Wealth Services first reported a position in AZN in Q1 2022 and has held it in 17 quarters since. The position peaked at $967K in Q2 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Confluence Wealth Services held 4,292 shares of AstraZeneca worth $814K as of Q2 2026.
- AstraZeneca was a new Confluence Wealth Services position in Q2 2026.
- AstraZeneca made up 0.02% of Confluence Wealth Services's portfolio in Q2 2026, its #263 holding.
- Confluence Wealth Services first reported a position in AstraZeneca in Q1 2022 and has held it in 17 quarters since.
- Confluence Wealth Services's AstraZeneca position peaked at $967K in Q2 2023.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.